Clinical Trial Update: Study of Bexarotene in Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Clinical trial update on a Phase 1 study of bexarotene in patients with acute myeloid leukemia; the trial status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: AML, Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED